Semaglutide

GLP-1 Agonist

Includes 2ml Bac Water vial

$60.00 AUD

Purity: 99%

Molecular structure:

Concentration: 3mg

Suggested diluent: Bacteriostatic water

Product summary:

Thid is a compound used to treat ongoing weight management in adults. Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

This is indicated as an adjunct to diet and exercise to improve glycemic control in adults. glucose). It reduces food intake by lowering appetite and slowing down digestion in the stomach, helping to reduce body fat.

Suppports:

Rapid weight loss

Significant fat reduction

Reduced hunger

Optimal metabolic function

Enhanced lean muscle capacity

Increased ability to diet effectively

Dosage: This is sold in vials containing 3mg of lyophilised powder which should be stored under refrigeration. (It is acceptable however for them to be mailed unrefrigerated). The contents can be reconstituted by adding a convenient amount of sterile or bacteriostatic water.

Benefits

Weight Management—Semaglutide, as a GLP-1 receptor agonist, has been shown in clinical studies to produce significant and sustained weight loss when combined with lifestyle modifications.
Appetite Regulation—It acts on brain centers, such as the hypothalamus, to reduce hunger, curb food cravings, and decrease thoughts about food.
Glycemic Control—Semaglutide enhances glucose-dependent insulin secretion, which helps lower blood glucose levels and improves HbA1c markers.
Gastric Emptying—The peptide slows down the rate at which the stomach empties, contributing to a prolonged feeling of fullness and satiety after meals.
Cardiometabolic Health—Research indicates that beyond weight loss, Semaglutide may offer cardiovascular benefits, including improvements in blood pressure and lipid profiles.

Potential Side Effects

Gastrointestinal Effects—The most common side effects are gastrointestinal in nature, including nausea, vomiting, diarrhea, and constipation, particularly during the initial dose-titration phase.
Pancreatitis Risk—Although rare, there is a noted risk of acute pancreatitis; researchers should be aware of symptoms like severe abdominal pain.
Gallbladder Issues—Some studies have reported an increased incidence of gallbladder-related issues, including cholelithiasis (gallstones).
Injection Site Reactions—Mild reactions such as redness, itching, or discomfort at the injection site may occur.

Shipping: Flat $15 standard shipping (~7 days) · Free over $150